The Dietary Inflammatory Index and Incident Risk of Type 2 Diabetes Mellitus: Interactions with Obesity and
Jinliang Liang1, Xueru Fu2, Yuying Wu2
1Department of Biostatistics and Epidemiology, School of Public Health, Shenzhen University Medical School, Shenzhen 518060, China.
Objectives:
To explore the association between the dietary inflammatory index (DII) and type 2 diabetes mellitus (T2DM) risk and to evaluate potential interactions of obesity and dyslipidemia in the context of this association.
Methods:
This cohort study included 8055 adults. Dietary data from food frequency questionnaires were used to calculate DII, reflecting dietary inflammatory potential. T2DM was defined as fasting plasma glucose ≥7.0 mmol/L, HbA1c ≥6.5%, a documented T2DM history, or glucose-lowering therapy. Multivariate Cox regression models assessed the DII-T2DM association, with multiplicative interaction analysis via product terms and additive interactions evaluated using relative excess risk due to interaction (RERI) and attributable proportion due to interaction (AP).
Results:
After a median 5.01-year follow-up, 1034 incident T2DM cases had occurred. The highest versus lowest DII quartile showed an unadjusted HR of 1.20 (95% CI: 1.01-1.42), which attenuated after adjusting for demographic and clinical confounders. In women, the highest DII quartile had a significantly adjusted HR of 1.36 (1.03-1.81), with a 16% increased risk per 1-SD DII increase (adjusted HR:1.16, 95% CI:1.04-1.29); no association was observed in men. Positive multiplicative and additive interactions emerged in total participants between high DII and central obesity (measured by waist circumference/waist-to-hip ratio), accounting for 22% and 31% of excess T2DM risk, respectively. No interactions were found with dyslipidemia and other obesity metrics (BMI, waist-to-height ratio).
Conclusions:
This study suggests that a highly pro-inflammatory diet may be associated with an increased incident risk of T2DM among women. Waist circumference and waist-to-hip ratio and a high DII are found to act synergistically in elevating T2DM risk.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
10:17An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Related Concept Videos
01:24Obesity
01:22Diabetes Mellitus: Type 2 and Gestational
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Coronary Artery Disease I: Introduction
01:15Diabetes: Symptoms, Diagnosis, and Complications
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...